부은 무릎 치료 시장 규모, 점유율, 성장 분석 : 유형별, 약제별, 수술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Swollen Knee Treatment Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.28 Billion in 2025 to USD 3.25 Billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).

The market for swollen knee treatment is witnessing a transformative shift as patients increasingly favor non-surgical healthcare approaches. This emerging trend emphasizes the growing preference for therapeutic and propaedeutic techniques over conventional surgical procedures, highlighting a desire for minimally invasive and non-invasive options. Heightened awareness of the potential complications and side effects linked to surgical interventions, particularly knee arthroplasty, is driving this change in patient behavior. As individuals become more knowledgeable about the risks associated with surgical treatments, they are actively seeking alternative solutions that provide similar effectiveness while minimizing invasiveness and shortening recovery periods. This evolving landscape suggests a significant opportunity for innovative treatments that align with patients' preferences for safer, less invasive care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segments Analysis

Global Swollen Knee Treatment Market is segmented by Type, Medications, Surgery, End User and region. Based on Type, the market is segmented into Medications, Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery. Based on Medications, the market is segmented into Opioids, Corticosteroids and Others. Based on Surgery, the market is segmented into Arthrocentesis, Arthroscopy and Knee Replacement. Based on End User, the market is segmented into Hospitals, Designated Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Swollen Knee Treatment Market

One of the key market drivers for the global swollen knee treatment market is the increasing prevalence of obesity and related musculoskeletal disorders. As obesity rates continue to rise, more individuals are experiencing knee-related issues due to the added stress on joints, leading to conditions such as osteoarthritis and injury. This growing patient population necessitates effective treatment options, driving demand for therapies, medications, and rehabilitation services tailored to knee swelling. Additionally, heightened awareness of joint health and the importance of early intervention further contribute to the expansion of the swollen knee treatment market, as patients seek to alleviate discomfort and improve mobility.

Restraints in the Swollen Knee Treatment Market

One key market restraint for the global swollen knee treatment market is the high cost of advanced therapeutic options and surgical interventions. Many patients face financial barriers that limit their access to effective treatments, particularly in regions with less developed healthcare systems. This economic constraint is further compounded by a lack of insurance coverage for certain procedures, leading to delayed treatment and increased healthcare inequalities. Additionally, the availability of alternative, less expensive home remedies and over-the-counter medications may deter patients from seeking professional medical care, thereby affecting the overall growth potential of the swollen knee treatment market.

Market Trends of the Swollen Knee Treatment Market

The Swollen Knee Treatment market is witnessing a pronounced shift driven by the rapid advancements in medical device technology that enhance orthopedic care. Innovative treatments, particularly in knee braces, supports, and orthotic implants, are reshaping the landscape by offering improved patient comfort and outcomes. These devices cater to a wide range of knee-related conditions, from acute injuries to chronic ailments, by providing targeted support, stability, and alignment. As treatments become more specialized and adaptable, healthcare professionals can customize their approaches to meet the distinct needs of patients. This diversification of therapeutic options is fostering growth within the market, making it increasingly pivotal in orthopedic healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Swollen Knee Treatment Market Size by Type & CAGR (2026-2033)

• Market Overview
• Medications
• Patient-controlled Analgesia Pumps
• Nerve Blocks
• Liposomal Bupivacaine
• Surgery

Global Swollen Knee Treatment Market Size by Medications & CAGR (2026-2033)

• Market Overview
• Opioids
• Corticosteroids
• Others

Global Swollen Knee Treatment Market Size by Surgery & CAGR (2026-2033)

• Market Overview
• Arthrocentesis
• Arthroscopy
• Knee Replacement
  • Total Knee Replacement
  • Unicompartmental Knee Replacement
  • Others

Global Swollen Knee Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Designated Clinics
• Ambulatory Surgical Centers
• Others

Global Swollen Knee Treatment Market Size & CAGR (2026-2033)

• North America (Type, Medications, Surgery, End User)
  • US
  • Canada
• Europe (Type, Medications, Surgery, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Medications, Surgery, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Medications, Surgery, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Medications, Surgery, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ossur (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DJO Global (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medacta International (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exactech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Orthopedics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap Implant Systems (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tornier N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations